Epsilon M&A Deal Report - Bremer Pharma
Transaction Multiples for the Valuation of Private Companies
Zydus Animal Health (ZAHL) / Bremer Pharma
No EMAT :
38570
Announced Date :
27/07/2011
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Zydus Animal Health (ZAHL)
Target :
Bremer Pharma
Country :
Germany
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Bremer Pharma GmbH manufactures and distributes generic veterinary pharmaceutical products . > Manufactures powders, tablets, liquids and parenterals. Its entire product range includes Vitamins,...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 29/06/2011 | Private Group led by Herkules Private Equity | Hjelp24 | Norway | ** | 38520 |
| 27/09/2010 | Citi Venture Capital International (CVCI) | Huvepharma | Bulgaria | ** | 38507 |
Source: Epsilon Research / EMAT
